PNC Financial Services Group
IHE icon

PNC Financial Services Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

PNC Financial Services Group’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Hold
1,365
– – ﹤0.01% 2726
2026
Q1 		$118K Sell
1,365
-1,051
-44% -$92K ﹤0.01% 2697
2025
Q4 		$205K Sell
2,416
-1,658
-41% -$132K ﹤0.01% 2294
2025
Q3 		$296K Buy
4,074
+2,793
+218% +$193K ﹤0.01% 2030
2025
Q2 		$84K Hold
1,281
– – ﹤0.01% 2825
2025
Q1 		$90.4K Buy
1,281
+216
+20% +$15K ﹤0.01% 2728
2024
Q4 		$70K Hold
1,065
– – ﹤0.01% 2904
2024
Q3 		$75.2K Hold
1,065
– – ﹤0.01% 2842
2024
Q2 		$70.6K Hold
1,065
– – ﹤0.01% 2842
2024
Q1 		$72.3K Sell
1,065
-237
-18% -$15.7K ﹤0.01% 2799
2023
Q4 		$80.4K Hold
1,302
– – ﹤0.01% 2729
2023
Q3 		$76.7K Buy
1,302
+291
+29% +$17.9K ﹤0.01% 2735
2023
Q2 		$60.3K Hold
1,011
– – ﹤0.01% 2949
2023
Q1 		$59K Hold
1,011
– – ﹤0.01% 2887
2022
Q4 		$62.6K Hold
1,011
– – ﹤0.01% 2844
2022
Q3 		$57K Hold
1,011
– – ﹤0.01% 2880
2022
Q2 		$64K Hold
1,011
– – ﹤0.01% 2835
2022
Q1 		$65K Hold
1,011
– – ﹤0.01% 2960
2021
Q4 		$68K Hold
1,011
– – ﹤0.01% 2930
2021
Q3 		$61K Hold
1,011
– – ﹤0.01% 2944
2021
Q2 		$63K Hold
1,011
– – ﹤0.01% 2919
2021
Q1 		$60K Sell
1,011
-363
-26% -$21.9K ﹤0.01% 2878
2020
Q4 		$82K Hold
1,374
– – ﹤0.01% 2610
2020
Q3 		$75K Buy
1,374
+255
+23% +$13.8K ﹤0.01% 2482
2020
Q2 		$57K Buy
1,119
+3
+0.3% +$151 ﹤0.01% 2688
2020
Q1 		$50K Sell
1,116
-45
-4% -$2.27K ﹤0.01% 2628
2019
Q4 		$62K Buy
1,161
+3
+0.3% +$148 ﹤0.01% 2768
2019
Q3 		$54K Buy
1,158
+3
+0.3% +$144 ﹤0.01% 2857
2019
Q2 		$58K Sell
1,155
-237
-17% -$11.7K ﹤0.01% 2858
2019
Q1 		$71K Buy
1,392
+300
+27% +$14.9K ﹤0.01% 2755
2018
Q4 		$51K Buy
1,092
+231
+27% +$11.8K ﹤0.01% 2856
2018
Q3 		$48K Sell
861
-396
-32% -$21.6K ﹤0.01% 3020
2018
Q2 		$63K Sell
1,257
-141
-10% -$6.99K ﹤0.01% 2841
2018
Q1 		$69K Sell
1,398
-18
-1% -$924 ﹤0.01% 2773
2017
Q4 		$73K Sell
1,416
-246
-15% -$12.6K ﹤0.01% 2729
2017
Q3 		$87K Sell
1,662
-612
-27% -$31.4K ﹤0.01% 2604
2017
Q2 		$118K Buy
2,274
+249
+12% +$12.6K ﹤0.01% 2427
2017
Q1 		$102K Buy
2,025
+3
+0.1% +$149 ﹤0.01% 2479
2016
Q4 		$95K Buy
2,022
+246
+14% +$11.7K ﹤0.01% 2495
2016
Q3 		$88K Buy
1,776
+291
+20% +$14.8K ﹤0.01% 2523
2016
Q2 		$72K Sell
1,485
-1,500
-50% -$71.4K ﹤0.01% 2654
2016
Q1 		$136K Sell
2,985
-147
-5% -$6.88K ﹤0.01% 2336
2015
Q4 		$168K Sell
3,132
-375
-11% -$19.7K ﹤0.01% 2194
2015
Q3 		$174K Buy
3,507
+195
+6% +$11.2K ﹤0.01% 2208
2015
Q2 		$193K Buy
3,312
+801
+32% +$46.8K ﹤0.01% 2252
2015
Q1 		$143K Buy
2,511
+1,311
+109% +$71.7K ﹤0.01% 2471
2014
Q4 		$60K Hold
1,200
– – ﹤0.01% 2701
2014
Q3 		$56K Hold
1,200
– – ﹤0.01% 2634
2014
Q2 		$54K Hold
1,200
– – ﹤0.01% 2546
2014
Q1 		$50K Hold
1,200
– – ﹤0.01% 2502
2013
Q4 		$48K Hold
1,200
– – ﹤0.01% 2509
2013
Q3 		$42K Hold
1,200
– – ﹤0.01% 2564
2013
Q2 		$40K Buy
+1,200
New +$39.9K ﹤0.01% 2485

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PNC Financial Services Group's IHE Position: Q2 2026 in Review

PNC Financial Services Group held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 1,365 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #2726.

PNC Financial Services Group first reported a position in IHE in Q2 2013 and has held it in 53 quarters since. The position peaked at $296K in Q3 2025. 139 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • PNC Financial Services Group held 1,365 shares of iShares US Pharmaceuticals ETF worth $135K as of Q2 2026.
  • PNC Financial Services Group left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2726 holding.
  • PNC Financial Services Group first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 53 quarters since.
  • PNC Financial Services Group's iShares US Pharmaceuticals ETF position peaked at $296K in Q3 2025.
  • 139 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.